182 related articles for article (PubMed ID: 2889032)
1. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
[TBL] [Abstract][Full Text] [Related]
2. Liquorice-induced apparent mineralocorticoid excess presenting in the emergency department.
Gallacher SD; Tsokolas G; Dimitropoulos I
Clin Med (Lond); 2017 Feb; 17(1):43-45. PubMed ID: 28148579
[TBL] [Abstract][Full Text] [Related]
3. [Adverse effects of licorice consumed as food: An update].
Caré W; Grenet G; Schmitt C; Michel S; Langrand J; Le Roux G; Vodovar D
Rev Med Interne; 2023 Sep; 44(9):487-494. PubMed ID: 37005098
[TBL] [Abstract][Full Text] [Related]
4. Pseudohyperaldosteronism, liquorice, and hypertension.
Sontia B; Mooney J; Gaudet L; Touyz RM
J Clin Hypertens (Greenwich); 2008 Feb; 10(2):153-7. PubMed ID: 18256580
[TBL] [Abstract][Full Text] [Related]
5. Further studies on the mechanism of the mineralocorticoid action of licorice in humans.
Armanini D; Lewicka S; Pratesi C; Scali M; Zennaro MC; Zovato S; Gottardo C; Simoncini M; Spigariol A; Zampollo V
J Endocrinol Invest; 1996 Oct; 19(9):624-9. PubMed ID: 8957748
[TBL] [Abstract][Full Text] [Related]
6. Licorice-induced hypertension and syndromes of apparent mineralocorticoid excess.
Walker BR; Edwards CR
Endocrinol Metab Clin North Am; 1994 Jun; 23(2):359-77. PubMed ID: 8070427
[TBL] [Abstract][Full Text] [Related]
7. Licorice-induced pseudoaldosteronism. Hypertension, hypokalemia, aldosteronopenia, and suppressed plasma renin activity.
Conn JW; Rovner DR; Cohen EL
JAMA; 1968 Aug; 205(7):492-6. PubMed ID: 5695305
[No Abstract] [Full Text] [Related]
8. A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity.
Roth CL; Perez FA; Whitlock KB; Elfers C; Yanovski JA; Shoemaker AH; Abuzzahab MJ
Diabetes Obes Metab; 2021 Feb; 23(2):363-373. PubMed ID: 33026160
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.
Nakajima A; Seki M; Taniguchi S; Ohta A; Gillberg PG; Mattsson JP; Camilleri M
Lancet Gastroenterol Hepatol; 2018 Aug; 3(8):537-547. PubMed ID: 29805116
[TBL] [Abstract][Full Text] [Related]
10. Separation of phospholipase A2 in Habu snake venom by glycyrrhizin (GL)-affinity column chromatography and identification of a GL-sensitive enzyme.
Ohtsuki K; Abe Y; Shimoyama Y; Furuya T; Munakata H; Takasaki C
Biol Pharm Bull; 1998 Jun; 21(6):574-8. PubMed ID: 9657040
[TBL] [Abstract][Full Text] [Related]
11. Physiological correlation between glycyrrhizin, glycyrrhizin-binding lipoxygenase and casein kinase II.
Shimoyama Y; Ohtaka H; Nagata N; Munakata H; Hayashi N; Ohtsuki K
FEBS Lett; 1996 Aug; 391(3):238-42. PubMed ID: 8764981
[TBL] [Abstract][Full Text] [Related]
12. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice.
Abe N; Ebina T; Ishida N
Microbiol Immunol; 1982; 26(6):535-9. PubMed ID: 6290851
[No Abstract] [Full Text] [Related]
13. Glycyrrhizin beta-D-glucuronidase of Eubacterium sp. from human intestinal flora.
Akao T; Akao T; Kobashi K
Chem Pharm Bull (Tokyo); 1987 Feb; 35(2):705-10. PubMed ID: 3594680
[No Abstract] [Full Text] [Related]
14. Teratogenicity study of ammonium glycyrrhizinate in the Sprague-Dawley rat.
Mantovani A; Ricciardi C; Stazi AV; Macri C; Piccioni A; Badellino E; De Vincenzi M; Caiola S; Patriarca M
Food Chem Toxicol; 1988 May; 26(5):435-40. PubMed ID: 3391466
[TBL] [Abstract][Full Text] [Related]
15. Antiviral activity of glycyrrhizin against varicella-zoster virus in vitro.
Baba M; Shigeta S
Antiviral Res; 1987 Feb; 7(2):99-107. PubMed ID: 3034150
[TBL] [Abstract][Full Text] [Related]
16. Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action.
Whorwood CB; Sheppard MC; Stewart PM
Endocrinology; 1993 Jun; 132(6):2287-92. PubMed ID: 8504732
[TBL] [Abstract][Full Text] [Related]
17. Low Cortisone as a Novel Predictor of the Low-Renin Phenotype.
Tapia-Castillo A; Carvajal CA; Pérez JA; Sandoval A; Allende F; Solari S; Fardella CE
J Endocr Soc; 2024 Apr; 8(6):bvae051. PubMed ID: 38586159
[TBL] [Abstract][Full Text] [Related]
18. Plant vs. Kidney: Evaluating Nephrotoxicity of Botanicals with the Latest Toxicological Tools.
Pearson A; Gafner S; Rider CV; Embry M; Ferguson SS; Mitchell CA
Curr Opin Toxicol; 2022 Dec; 32():. PubMed ID: 36311298
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic insights into the primary and secondary alterations of renal ion and water transport in the distal nephron.
Tabibzadeh N; Crambert G
J Intern Med; 2023 Jan; 293(1):4-22. PubMed ID: 35909256
[TBL] [Abstract][Full Text] [Related]
20. Recurrent Hypokalemia and Adrenal Steroids in Patients With APECED.
Borchers J; Mäkitie O; Jääskeläinen J; Laakso S
Front Endocrinol (Lausanne); 2022; 13():904507. PubMed ID: 35813662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
